Stockholders approve issuance of shares exceeding 20% of outstanding common stock

OS Therapies Inc

Special meeting held April 9, 2025; proposal passed with 11,587,018 votes in favor (99.3% of votes cast).
Approval covers conversion of 1,775,750 Series A Preferred shares and exercise of warrants from private placement.
Issuance without regard to conversion/exercise limits can dilute existing holders by at least 20%.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.